Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Influenza
Influenza.png
Filter     Order     Display # 
Date Item Title Hits
05 Nov 2009 Daiichi Sankyo Launches New Phase 3 Trial with CS-8958 for Flu Prevention 697
25 May 2007 Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza 1455
16 May 2007 Next Generation Nasal Spray Against Influenza: Clinical Phase I Study Started With FLUVACCdelNS1 907
08 May 2007 4SC AG Provides Proof of Concept for Drug Candidate SC75741 in the Treatment of Influenza A-infected Mice 884
08 May 2007 Focetria(R), the Novartis pandemic influenza vaccine, receives European Union approval 866
03 May 2007 ANX-201 Drug Combination Demonstrates Synergistic Activity Against Human and Bird Flu Viruses 834
27 Apr 2007 Optaflu(R), the Novartis cell culture-derived influenza vaccine, receives positive opinion supporting European Union regulatory approval 1114
18 Apr 2007 Completion of Phase I Trial on the Anti-influenza Drug CS-8958 991
04 Apr 2007 CytoGenix Announces Successful Testing of synDNA(TM) Vaccine for Avian Influenza Virus 907
02 Apr 2007 CSL Biotherapies Submits BLA to Introduce Flu Vaccine to U.S. Market 924
02 Apr 2007 Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data Show 889
29 Mar 2007 Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 891
05 Mar 2007 New studies indicate GSK's pre-pandemic influenza vaccine can protect against different strains of H5N1 1019
23 Feb 2007 Focetria(R) pandemic influenza vaccine receives positive European Union regulatory agency opinion supporting approval 1010
21 Feb 2007 Pre-Clinical Study of Novavax's Seasonal Influenza Vaccine Published in Journal 'Vaccine' 1045
30 Jan 2007 BioSante Pharmaceuticals Announces Positive Bird Flu Results Using Proprietary Vaccine Adjuvant in Pre-Clinical Study 1441
29 Jan 2007 GlaxoSmithKline files its new pre-pandemic influenza vaccine in Europe 1163
25 Jan 2007 Biocryst Initiates Phase II Influenza Clinical Trial To Evaluate Peramivir 1128
15 Dec 2006 GlaxoSmithKline reaches EU regulatory milestone in its flu pandemic vaccine development programme 1231
09 Nov 2006 MedImmune Files Investigational New Drug Application for Cell Culture-Based Influenza Vaccine 1236
08 Nov 2006 Novavax's Pandemic Influenza Vaccine Candidates Trigger Robust Immune Response In Pre-Clinical Models 1185
06 Nov 2006 Generex Biotechnology to Begin the First Human Clinical Trial of Avian Influenza Vaccine 1200
20 Oct 2006 Single Injection of Vical's Avian Flu DNA Vaccine Provides 100% Protection in Ferrets 1303
18 Oct 2006 MediVas, LLC Announces Positive Preclinical Ferret Data Against H5N1 1319
04 Oct 2006 Baxter Announces Safety and Immunogenicity Results from Phase I/II Clinical Trial of Cell-Based Candidate H5N1 Pandemic Vaccine 1417
26 Sep 2006 Sanofi pasteur Cell Culture-Based Seasonal Influenza Vaccine Enters First Clinical Trial 1549
28 Aug 2006 Preliminary Result of Phase I Clinical Trial Shows That Sinovac's Pandemic Influenza Vaccine (H5N1) has High Safety and Immunogenicity Profile 1419
21 Aug 2006 Dynavax's Flu Vaccine Shows Immunity to Divergent and Potentially Pandemic Flu Strains in Preclinical Tests 1326
31 Jul 2006 Novavax Succeeds in Making Vaccine to Protect Against New Mutation of Avian Influenza 1314
31 Jul 2006 MedImmune Submits Refrigerator-Stable Formulation of FluMist® to FDA for Approval in Younger Children 1396
 
<< Start < Prev 1 2 3 Next > End >>
Results 1 - 30 of 83

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Biologic and Immune Therapy of S. aureus Infections

Order Now

Recommended Report

RNA Therapeutics
Order Now

Subscribe La Merie Biologics